Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jelle Kylstra, Mike Ward

Premium

Atossa Genetics announced the hiring of Jelle Kylstra as its new VP of clinical research and development. Kylstra joined the company on May 19, and brings with her more than 23 years of industry experience.

Before joining Atossa, Kylstra was VP of global clinical affairs at Spectrum Pharmaceuticals. Prior to that, Kylstra held various leadership roles at AngioDynamics, Light Sciences Corp., and other firms.


BioNano Genomics announced that Mike Ward will serve as its VP of corporate development. Ward brings to the company more than two decades of experience in life sciences-related investment banking, venture capital, and private equity.

Ward comes to BioNano from Lurie Investment Fund. He has worked at various investment banks, including Leerink Partners, Credit Suisse, and others.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.